Molecular Mechanisms and Therapies of Hematological Tumors
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 171
Special Issue Editors
Interests: leukemia; diagnostic; MPN; NGS
Interests: acute myeloid leukemia; genomics; cell metabolism; targeted therapies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hematological malignancies consist of different cancers including leukemias, lymphomas, multiple myeloma, myeloproliferative neoplasms, and myelodysplastic syndromes. Recent advances in sequencing technologies have better defined the genomic landscape of hematological diseases and partially explained the molecular mechanisms underlying the carcinogenesis processes. This led to the development of different target therapies such as IDH inhibitors or BCL2 inhibitors that can be used beyond the standard chemotherapy to target and resolve the complexity of hematological disease and improve patient outcomes. Recently, the pathogenic roles of KMT2A rearrangements have been elucidated and patients characterized by this structural alteration can take advantage from Menin inhibitor use. Despite this, leukemic stem cells possess different relapse/refractory mechanisms, for example, multi-drug resistance, responsible for the relapse of disease.
This Special Issue aims to explain new insights into genetic and epigenetic alterations, cancer metabolism, target therapies, therapy response, drug resistance and relapse of the disease. Both original research articles, including in vitro studies, and reviews articles are strongly invited for submission.
Dr. Maria Teresa Bochicchio
Dr. Giorgia Simonetti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetic alterations
- next-generation sequencing
- molecular biomarkers
- target therapy
- drug resistance
